BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21804527)

  • 21. [Pathological and clinical features of malignant thyroid tumors: classification, immunohistology, prognostic criteria].
    Schröder S
    Veroff Pathol; 1988; 130():1-159. PubMed ID: 3213226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of extent of vascular invasion in low-grade encapsulated follicular cell-derived thyroid carcinomas: a clinicopathologic study of 276 cases.
    Xu B; Wang L; Tuttle RM; Ganly I; Ghossein R
    Hum Pathol; 2015 Dec; 46(12):1789-98. PubMed ID: 26482605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.
    Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg; 2005 Nov; 242(5):708-15. PubMed ID: 16244545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.
    Maletta F; Massa F; Torregrossa L; Duregon E; Casadei GP; Basolo F; Tallini G; Volante M; Nikiforov YE; Papotti M
    Hum Pathol; 2016 Aug; 54():134-42. PubMed ID: 27085556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distant metastases in differentiated thyroid carcinomas: a clinical and pathologic study.
    Mizukami Y; Michigishi T; Nonomura A; Hashimoto T; Terahata S; Noguchi M; Hisada K; Matsubara F
    Hum Pathol; 1990 Mar; 21(3):283-90. PubMed ID: 2312106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation.
    Bae JS; Kim Y; Jeon S; Kim SH; Kim TJ; Lee S; Kim MH; Lim DJ; Lee YS; Jung CK
    Diagn Pathol; 2016 Feb; 11():21. PubMed ID: 26857243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA class II expression in well differentiated thyroid carcinoma: correlation with clinicopathological features.
    Knoll MR; Schwab M; Oestreich K; Rumstadt B; Hagmüller E
    J Exp Clin Cancer Res; 1997 Jun; 16(2):177-82. PubMed ID: 9261744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.
    Chang HY; Lin JD; Chou SC; Chao TC; Hsueh C
    Jpn J Clin Oncol; 2006 Nov; 36(11):688-93. PubMed ID: 17000702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
    Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphoproteomics demonstrates activation of mammalian target of rapamycin pathway in papillary thyroid carcinomas with nuclear translocation of MTOR in aggressive histological variants.
    Liu J; Brown RE
    Mod Pathol; 2011 Dec; 24(12):1553-9. PubMed ID: 21822208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and Clinicopathological Features of Differentiated High-Grade Thyroid Carcinomas: An Institutional Experience.
    Jeong SI; Kim W; Yu HW; Choi JY; Ahn CH; Moon JH; Choi SI; Cha W; Jeong WJ; Park SY; Na HY
    Endocr Pathol; 2023 Sep; 34(3):287-297. PubMed ID: 37515661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Invasion rather than nuclear features correlates with outcome in encapsulated follicular tumors: further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant.
    Ganly I; Wang L; Tuttle RM; Katabi N; Ceballos GA; Harach HR; Ghossein R
    Hum Pathol; 2015 May; 46(5):657-64. PubMed ID: 25721865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of Tumor Capsule Thickness as a Predictor of Invasion in Encapsulated Follicular Variant of Papillary Thyroid Carcinoma and a Diagnostic Tool for Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features.
    French B; Hattier G; Mardekian SK
    Int J Surg Pathol; 2020 Feb; 28(1):13-19. PubMed ID: 31256687
    [No Abstract]   [Full Text] [Related]  

  • 34. Co-regulatory potential of vascular endothelial growth factor-A and vascular endothelial growth factor-C in thyroid carcinoma.
    Salajegheh A; Pakneshan S; Rahman A; Dolan-Evans E; Zhang S; Kwong E; Gopalan V; Lo CY; Smith RA; Lam AK
    Hum Pathol; 2013 Oct; 44(10):2204-12. PubMed ID: 23845470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early recurrence of papillary and follicular thyroid carcinoma predicts a worse outcome.
    Lin JD; Hsueh C; Chao TC
    Thyroid; 2009 Oct; 19(10):1053-9. PubMed ID: 19772423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Larger tumor size predicts nodal involvement in patients with follicular thyroid carcinoma.
    Pisanu A; Deplano D; Pili M; Uccheddu A
    Tumori; 2011; 97(3):296-303. PubMed ID: 21789006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.
    Lin JD; Huang MJ; Juang JH; Chao TC; Huang BY; Chen KW; Chen JY; Li KL; Chen JF; Ho YS
    Thyroid; 1999 Dec; 9(12):1227-35. PubMed ID: 10646663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should subcentimeter non-invasive encapsulated, follicular variant of papillary thyroid carcinoma be included in the noninvasive follicular thyroid neoplasm with papillary-like nuclear features category?
    Xu B; Farhat N; Barletta JA; Hung YP; Biase D; Casadei GP; Onenerk AM; Tuttle RM; Roman BR; Katabi N; Nosé V; Sadow P; Tallini G; Faquin WC; Ghossein R
    Endocrine; 2018 Jan; 59(1):143-150. PubMed ID: 29204912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of epithelial-mesenchymal transition regulators TWIST, SLUG and SNAIL in follicular thyroid tumours may relate to widely invasive, poorly differentiated and distant metastasis.
    Wu J; Zhang Y; Cheng R; Gong W; Ding T; Zhai Q; Wang Y; Meng B; Sun B
    Histopathology; 2019 Apr; 74(5):780-791. PubMed ID: 30368884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid].
    Wang T; Jiang CX; Li Y; Liu X
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):824-8. PubMed ID: 20193458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.